Home > Companies > Global Health Drug Discovery Institute

Global Health Drug Discovery Institute

ghddi.org

The Global Health Drug Discovery Institute (GHDDI) identifies and develops innovative approaches to new medicines for diseases most damaging to populations in the developing world. Diseases of particular focus are tuberculosis, malaria, diarrhea and parasitic infections etc. Being the first independent, not-for-profit research institute of its kind in China, GHDDI strives to establish a transformative drug discovery and translational platform with advanced biomedical research and development capabilities - from the bench to the bedside. GHDDI is jointly founded by the Bill and Melinda Gates Foundation, Tsinghua University, and the Beijing Municipal Government, and is closely partnered with the California Institute for Biomedical Research (Calibr) in scientific research.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

Health Care Facilities Innovation Conference

Conference

The 10th International Conference on Public Health

Conference

2024 Geneva Health Forum Conference

Conference

Related News

TENCENT ANNOUNCES AIMIS MEDICAL IMAGE CLOUD TO HELP MEDICAL DATA MANAGEMENT AND ACCELERATE INCUBATION OF MEDICAL AI APPLICATION

Tencent | October 20, 2020

Today, Tencent announced at the 83rd China International Medical Device Expo (CMEF) two new products that will enable consumers and medical professionals to safely and securely share medical data more easily, and equip medical professionals new tools to diagnose patients and achieve better patient outcomes. The Tencent AIMIS Medical Image Cloud, where patients can manage their images generated by X-rays, CT, and MRIs to...

KAISER PERMANENTE JOINS FORCES WITH CIVICA RX TO IMPROVE AVAILABILITY AND AFFORDABILITY OF ESSENTIAL GENERIC MEDICATIONS

Kaiser Permanente | June 19, 2020

Kaiser Permanente, the nation's largest nonprofit, integrated health system, announced that it is joining with nonprofit Civica Rx in its mission of assuring that health providers nationally have access to stable and affordable supplies of essential generic medications throughout the COVID-19 pandemic and beyond. Kaiser Permanente joins Civica as a governing member with a seat on the board of directors and as an integrated health system with 12.4 million members will provide a...

VIDEO API POWERS TELEMEDICINE COMPANIES DURING COVID-19

HITInfrastructure | April 08, 2020

Cloud communication company Vonage returning higher demand for its video application program interface (API) as telemedicine companies leverage the technology to facilitate virtual visits during the COVID-19 pandemic. While video conferencing has been in the headlines of late, the growth in video-based applications is even more important. In particular, video-based applications are powering essential telehealth services during this public health crisis,” Alan Masarek, Vonage CEO, said in t...

Future of Healthcare

RLDATIX COMPLETES ACQUISITION OF ALLOCATE SOFTWARE

RLDatix | September 23, 2021

RLDatix, the international leader in governance, risk and compliance (GRC) solutions for healthcare, announced today the completion of the acquisition of UK-based Allocate Software (“Allocate”), a leading provider of human capital management solutions that help healthcare organisations deliver safe and effective care. The acquisition was previously announced on June 28th, 2021. With the completion of this acquisition, RLDatix cements its position as the ...